Overactive bladder in men: special considerations for evaluation and management 1 1 Roger R. Dmochowski is on the medical advisory board for Lilly, Watson, and OMP Pharmaceuticals, and he is a study investigator funded by Surx, Lilly, Watson, Roche, and Schwartz. David R. Staskin is a paid consultant to Ortho-McNeil, Pfizer, Indevus, Kyowa, Yamanouchi, Roche, and Lilly.
Title:
Overactive bladder in men: special considerations for evaluation and management 1 1 Roger R. Dmochowski is on the medical advisory board for Lilly, Watson, and OMP Pharmaceuticals, and he is a study investigator funded by Surx, Lilly, Watson, Roche, and Schwartz. David R. Staskin is a paid consultant to Ortho-McNeil, Pfizer, Indevus, Kyowa, Yamanouchi, Roche, and Lilly.
Journal description